Table 1.
Baseline and clinical characteristics of the patients with SMV thrombosis
| Characteristic | Patients (n=41) |
|---|---|
| Male | 31 (75.6) |
| Age (y) | 62.11±12.14 |
| Hypertension | 8 (19.5) |
| Diabetes | 7 (17.0) |
| Liver cirrhosis | 3 (7.3) |
| Stroke | 3 (7.3) |
| Smoking history | 17 (41.5) |
| Cause of SMV thrombosis | |
| Intraperitoneal inflammation | 27 (65.9) |
| Malignancy | 7 (17.1) |
| Unknown | 7 (17.1) |
| Abdominal pain | 33 (80.5) |
| Fever | 13 (31.7) |
| Symptom duration (d) | 12.34±11.23 |
| Computed tomography findings | |
| Decreased bowel enhance | 6 (14.6) |
| Bowel swelling | 21 (51.2) |
| Portal vein extension | 16 (39.0) |
| Splenic vein extension | 10 (24.4) |
| IMV thrombosis | 2 (4.9) |
| White blood cell (×103/μL) | 9.63±3.56 |
| C-reactive protein (mg/dL) | 8.98±6.12 |
Values are presented as number (%) or mean±standard deviation.
SMV, superior mesenteric vein; IMV, inferior mesenteric vein.